SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is being done to answer the following question: Is the chance of cancer spreading or returning the same if radiotherapy to the neck is guided, by using a special imaging study called lymph node mapping (lymphatic mapping) Single Photon Emission Computed Tomography (SPECT-CT), compared to the usual treatment when radiotherapy is given to both sides of the neck?
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzona diagnoza raka gardła po jednej stronie, nieprzekraczającego linii środkowej
- •Zaawansowanie nowotworu stadium T1-T3 bez przerzutów do odległych narządów
- •Badania obrazowe (tomografia, rezonans lub PET) wykonane w ciągu 8 tygodni
- •Planowane napromienianie obu stron szyi (opcjonalnie z chemioterapią)
- •Możliwość rozpoczęcia leczenia w ciągu 28 dni od włączenia do badania
- •Dobry stan ogólny organizmu (skala ECOG 0-2)
- •Chęć wypełniania ankiet dotyczących jakości życia
- •Dostępność do leczenia i wizyt kontrolnych
✗ Disqualifies
- •Raki stadium T1-T2 (niska zaawansowana choroba)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (38)
City of Hope Corona
Corona, United States
City of Hope Comprehensive Cancer Center
Duarte, United States
City of Hope at Irvine Lennar
Irvine, United States
UM Sylvester Comprehensive Cancer Center at Coral Gables
Coral Gables, United States
Baptist MD Anderson Cancer Center
Jacksonville, United States
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, United States
Moffitt Cancer Center-International Plaza
Tampa, United States
Moffitt Cancer Center - McKinley Campus
Tampa, United States
Moffitt Cancer Center
Tampa, United States
Emory University Hospital Midtown
Atlanta, United States
Northwestern University
Chicago, United States
Northwestern Medicine Cancer Center Warrenville
Warrenville, United States
The James Graham Brown Cancer Center at University of Louisville
Louisville, United States
University of Michigan Rogel Cancer Center
Ann Arbor, United States
University of Michigan - Brighton Center for Specialty Care
Brighton, United States
Henry Ford Hospital
Detroit, United States
MU Health - University Hospital/Ellis Fischel Cancer Center
Columbia, United States
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, United States
MetroHealth Medical Center
Cleveland, United States
Providence Portland Medical Center
Portland, United States
UT MD Anderson - The Woodlands
Conroe, United States
UT MD Anderson Cancer Center
Houston, United States
UT MD Anderson - West Houston
Houston, United States
UT MD Anderson - League City
League City, United States
UT MD Anderson - Sugar Land
Sugar Land, United States
Central Vermont Medical Center/National Life Cancer Treatment
Berlin Corners, United States
University of Vermont Medical Center
Burlington, United States
University of Vermont and State Agricultural College
Burlington, United States
BCCA-Vancouver Cancer Centre
Vancouver, Canada
CancerCare Manitoba
Winnipeg, Canada
Health Sciences North
Greater Sudbury, Canada
Saint Joseph's Healthcare Charlton Campus
Hamilton, Canada
Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Canada
Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Canada
University Health Network-Princess Margaret Hospital
Toronto, Canada
CHUM - Centre Hospitalier de l'Universite de Montreal
Montreal, Canada
Jewish General Hospital
Montreal, Canada
Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Sherbrooke, Canada
Trial contact
Wendy Parulekar
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.